Physician profile
Charles Leinberry
NPI 1073563078
$3,082,370.79
in general payments reported to CMS, 2019-2025
10 companies · $71K in 2025
The $71K reported for 2025 was more than what 98% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767K · 2020: $629K · 2021: $541K · 2022: $448K · 2023: $351K · 2024: $278K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $699K · Food and Beverage: $19.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $698,851.01 |
| Food and Beverage | $19.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,976,725.98 | 2019-2025 | Accuport Cannula |
| Trice Medical, INC. | $66,796.48 | 2019-2025 | |
| Globus Medical, INC. | $38,287.56 | 2019-2025 | Distal Radius Plate, Anthem, Headless Compression Screw |
| Smith+Nephew, INC. | $138.67 | 2021 | |
| Skeletal Dynamics INC | $117.65 | 2019 | |
| Djo, LLC | $104.16 | 2019 | |
| Wright Medical Technology, INC. | $100.00 | 2019 | |
| Tenex Health INC. | $43.66 | 2021 | |
| Checkpoint Surgical, INC | $37.19 | 2019 | |
| Fidia Pharma USA INC. | $19.44 | 2025 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Leinberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.